Health Net (NYSE:HNT), a managed care company, disclosed in a regulatory filing Monday that it will be reaffirming its earnings guidance for fiscal 2014 at the Barclays Global Healthcare Conference on Tuesday. The company had previously said that it is expecting fiscal 2014 earnings of at least $3.00 per share and revenue of $14.4 billion. Analysts polled by Capital IQ are expecting EPS of $2.39 on revenue of $14.2 billion. Health Net (NYSE:HNT) shares closed at $35.09 with a 52-week range of $25.40 – $35.16.
Perfect World (NASDAQ:PWRD) is firmer in after hours trading after the online gaming company reported better-than-expected Q4 financial results and provided Q1 revenue guidance also topping Street estimates. Shares are up 2.6% at $23.99 apiece in after-hours trading, within a 52-week range of $9.72 to $26.25 a share. The online game developer and operator reported Q4 earnings of RMB 3.33 or $0.54 per ADS, ex one-time items, compared with $0.47 per ADS last year and beating the Capital IQ consensus by $0.05 per share. Looking forward to the current quarter, Perfect World (NASDAQ:PWRD) expects Q1 revenues of $137 million to $144.49 million, up as much as 43% over year-ago levels. The Street view is looking for $131.46 million in quarterly revenue.
Perfect World (NASDAQ:PWRD) closed down 6.5% but has regained most of those losses pre-market.
Shares of Wright Medical Group Inc. (NASDAQ:WMGI) were slightly lower in late Monday trading after a 1.5% higher close. The medical device company announces a deal with the U.S. Food and Drug Administration, which has agreed to accept the company’s data on its Augment bone graft for review rather than moving ahead with a hearing before a dispute resolution panel in mid-May. The agreement between Wright Medical Group Inc. (NASDAQ:WMGI) and the FDA’s Office of Device Evaluation remains subject to final approval by the federal agency’s appeal authority.
That approval is expected soon, the FDA said. Under terms of the revised agreement, Wright Medical Group Inc. (NASDAQ:WMGI) expects to expects to submit a pre-marketing application with the FDA for the bone graph material by March 31. The PMA is expected to contain x-rays and other radiographic films of study subjects at various pre-operative and post-operative time points while the FDA has promised an “expeditious review.”
Douglas Dynamics (NYSE:PLOW) stock jumped to an early after-hours high of $17.50 after an earnings beat and raised dividend before dropping back for some brief consolidation around 17. A blip to 17.25 brought a quick round of selling that dropped the stock briefly to around 16.10 were it was scooped up to trade again up to consolidation near 17. The stock could open on either side of that line but any early dips below 17 in Tuesday’s pre-market could be a potential near-term floor support for longs to watch. Likewise, on the upside, the 17.25 mark was tested and held a couple of times, a potential target for shorts.